HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered donor cells aim to shield transplant patients from dangerous viruses
Disease control Not yet recruitingThis trial tests whether giving patients a special type of donor immune cell, called CD45RA-depleted DLI, can prevent serious viral infections after a stem cell transplant. The study includes 30 high-risk patients who have received a transplant for blood cancer. Researchers will …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Fertility shield: goserelin injection may preserve ovarian function after stem cell transplant
Disease control Not yet recruitingThis study tests whether a single injection of goserelin, given just before a stem cell transplant, can help preserve ovarian function in women with blood cancers. The trial will enroll 64 women aged 14 to 50 and measure if their menstrual cycles return naturally within six month…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug aims to stop transplant complications in blood cancer patients
Disease control Not yet recruitingThis phase II trial tests whether adding the drug axatilimab to standard care can prevent graft-versus-host disease (GVHD) in 72 blood cancer patients receiving a stem cell transplant. GVHD occurs when donor cells attack the patient's body, causing serious symptoms. Axatilimab is…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a feeding tube after transplant save the gut?
Disease control Not yet recruitingThis study tests whether starting tube feeding right after a stem cell transplant can reduce severe gut graft-versus-host disease (GVHD) in people with blood cancers or disorders. About 112 participants will be randomly assigned to either standard care or early tube feeding. The …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can the RSV vaccine protect the most vulnerable? new study aims to find out
Disease control Not yet recruitingThis study tests whether the RSV vaccine Abrysvo can help blood cancer patients who have had a stem cell transplant or CAR-T therapy build immunity against RSV. Researchers will measure antibody levels before and after vaccination in 30 adults. The goal is to see if the vaccine t…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Prepping the body before transplant: new study tests exercise program to boost recovery
Disease control Not yet recruitingThis study tests whether a personalized program of exercise, education, and support before a stem cell transplant can improve strength, reduce frailty, and enhance quality of life in adults with blood cancer. About 68 participants will be randomly assigned to either the prehabili…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Hospital del Salvador • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can an iPad detect brain toxicity before doctors can? new study aims to find out
Diagnosis Not yet recruitingThis pilot study will test whether an iPad app called DCog Short can spot early signs of brain-related side effects (neurotoxicity) in 40 adults receiving CAR-T cell therapy for blood cancers. Participants will use the app to self-report symptoms, and researchers will compare the…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New trial aims to slash deadly bloodstream infections from hospital tubes
Prevention Not yet recruitingThis study will test different methods to prevent infections and other problems from central lines (tubes placed in large veins) in 2,500 patients. It compares special antimicrobial caps and a skin anchor device against standard care. The goal is to find the best ways to keep pat…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: The University of Queensland • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Could virtual reality help patients recover faster from cell therapy?
Symptom relief Not yet recruitingThis study tests whether using an immersive virtual reality headset during exercise can improve motivation, adherence, and emotional well-being in adults undergoing cell therapy or stem cell transplant. Participants follow a therapeutic exercise program with or without VR. The tr…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Fundacin Biomedica Galicia Sur • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Study to reveal if younger donors boost transplant success
Knowledge-focused Not yet recruitingThis study looks at how the age of a stem cell donor affects outcomes for people with blood cancers. Researchers will analyze data from 5,000 patients who received a first stem cell transplant, comparing those who got cells from younger versus older donors. The goal is to provide…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Blood test could predict bleeding risk in cancer patients
Knowledge-focused Not yet recruitingThis study aims to create a score that uses a special blood test to predict bleeding risk in people with blood cancers and very low platelet counts. Researchers will take an extra blood sample from 410 participants and analyze it with viscoelastometric tests. The goal is to ident…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Centre Hospitalier Annecy Genevois • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hidden parasites may worsen blood diseases, new study warns
Knowledge-focused Not yet recruitingThis study will check how common parasitic infections are in 285 people with blood disorders, like anemia or blood cancers, at Assiut University hospitals in Egypt. Researchers will test for Toxoplasma and other parasites. The goal is to understand if routine screening could help…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New study tracks brain health in kids after stem cell transplants
Knowledge-focused Not yet recruitingThis observational study will follow 100 children in Denmark who receive a stem cell transplant for blood cancer or other serious blood disorders. Researchers will test their thinking skills, physical abilities, and daily activity before the transplant and for one year after. The…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New study tracks patient Well-Being during advanced cancer treatments
Knowledge-focused Not yet recruitingThis observational study follows 162 patients with blood cancers who are receiving either a stem cell transplant or CAR-T therapy. Researchers will use a questionnaire to measure how symptoms and quality of life change from the start of hospital stay to discharge. The goal is to …
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Associazione Qol-one • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New tool to measure Cancer's financial toll tested in turkey
Knowledge-focused Not yet recruitingThis study aims to adapt a questionnaire called PROFFIT, originally developed in Italy, to measure financial toxicity (the financial burden of cancer treatment) in Turkish patients. Researchers will enroll 320 adults with cancer who have received treatment in the last three month…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Akdeniz University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Heart risks after stem cell transplants under the microscope
Knowledge-focused Not yet recruitingThis study will follow 400 people receiving a stem cell transplant to see how often they develop heart problems like heart attacks, irregular heartbeat, or heart failure. Researchers will use heart scans, blood tests, and other tools to find early warning signs. The goal is to be…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:45 UTC